Simulation platforms Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
21:42
Sep 17
Aaref Hilaly Partner, Bain Capital Ventures TBPN
Post-AGI unlocks robotics, drugs, simulation.
Aaref Hilaly argues that once intelligence becomes abundant post-AGI, new capabilities will emerge in areas like robotics, drug discovery, simulation platforms, and AI applications. These are not just incremental improvements; they can unlock tasks humans cannot do today, such as robots doing household chores, AI discovering new drugs, and simulation tools for better decision-making. He cites private companies like Sunday Robotics, Chai Discovery, and Simile as early examples.
MED

About Simulation platforms Investor Commentary

Across the available history and selected sources, Buzzberg tracks Simulation platforms across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Past 7 days, before deduplication: 1 bullish. Latest voices: Aaref Hilaly.